mechanism of glp 1 Mechanisms by which GLP-1 agonists may exert beneficial effects on the New research identifies a mechanism

These effects are dose-dependent and require systemic exposure to the medication

Physician approved treatment options Access customized medications selected by your physician based on your health profile

SGLT2 inhibitors are ideal for Type 2 diabetic patients who: Have existing heart disease or heart failure Have early kidney disease (CKD stage 13) Are overweight and need mild weight reduction Have high blood pressure alongside diabetes Want to avoid insulin for as long as possible Who Should NOT Take SGLT2 Inhibitors

PMID: 34626851 Dungan K, DeSantis A (2016): Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus

Patients deserve clear, honest information about what they are choosing, and MEDVi provides none

Park B et al